Literature DB >> 16616844

Polyneuropathies in teenagers: a clinicopathological study of 45 cases.

E Kararizou1, N Karandreas, P Davaki, R Davou, D Vassilopoulos.   

Abstract

The aim of the present study was to investigate the causes of polyneuropathy in teenagers and to describe some characteristic clinical, laboratory, electrophysiological and pathological features. Forty-five patients with peripheral nervous disorders aged 13-19 were studied. Hereditary polyneuropathy of different types was diagnosed in 28 patients (62%); nine showed chronic inflammatory demyelinating polyneuropathy (CIDP) and two showed vasculitic neuropathy. In two more cases polyneuropathy was attributed to toxic agents, while among the rest, one was diagnosed as metachromatic leucodystrophy (juvenile type), one as adrenoleucodystrophy, one as porphyric neuropathy and one as Fabry disease. The high incidence of hereditary neuropathies in teenagers differs from that in adults, but is similar to that encountered in children. In our study, CIDP appears to be a frequent cause of neuropathy in teenagers, while the other causes are broadly similar to those found in studies concerning children rather than adults.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616844     DOI: 10.1016/j.nmd.2006.03.001

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  2 in total

1.  X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.

Authors:  Marc Engelen; Stephan Kemp; Marianne de Visser; Björn M van Geel; Ronald J A Wanders; Patrick Aubourg; Bwee Tien Poll-The
Journal:  Orphanet J Rare Dis       Date:  2012-08-13       Impact factor: 4.123

2.  Surgical treatment and intraoperative spinal cord monitoring in scoliosis associated with chronic inflammatory demyelinating polyneuropathy: a case report.

Authors:  Daisuke Kudo; Naohisa Miyakoshi; Michio Hongo; Yuji Kasukawa; Yoshinori Ishikawa; Akiko Misawa; Yoichi Shimada
Journal:  Ups J Med Sci       Date:  2013-01-11       Impact factor: 2.384

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.